07:03 EST Bristol Myers to acquire RayzeBio for $62.50 per share in cash
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BMY:
- Early notable gainers among liquid option names on December 22nd
- M & A News: Bristol-Myers (NYSE:BMY) to Acquire Karuna for $14B
- Bristol Myers to acquire Karuna Therapeutics for $330 per share in cash
- Bristol Myers confirms acquisition of Karuna Therapeutics for $330.00 per share
- Bristol Myers to acquire Karuna Therapeutics for $14B, WSJ reports
Questions or Comments about the article? Write to editor@tipranks.com